Table 2 Frequency of outcomes
 Total (n = 13,156) | With FHpCVD (n = 2684) | Without FHpCVD (n = 10,472) |
|---|---|---|
 All-cause mortality | 295 (11%) | 1583 (15.1%) |
 Non-fatal CVEs | 517 (19.3%) | 1583 (15.1%) |
 ACS | 371 (13.8%) | 1087 (10.4%) |
 Stroke/TIA | 72 (2.7%) | 279 (2.6%) |
 Repeat revascularization | 74 (2.8%) | 217 (2.1%) |
 With prior MI or PCI (n = 5753) | With FHpCVD (n = 1214) | Without FHpCVD (n = 4539) |
|---|---|---|
 All-cause mortality | 167 (13.7%) | 709 (15.6%) |
 Non-fatal CVEs | 230 (18.9%) | 703 (15.5%) |
 ACS | 154 (12.7%) | 472 (10.4%) |
 Stroke/TIA | 41 (3.3%) | 129 (2.8%) |
 Repeat revascularization | 35 (2.9%) | 102 (2.3%) |
 No prior MI or PCI (n = 7403) | With FHpCVD (n = 1470) | Without FHpCVD (n = 5933) |
|---|---|---|
 All-cause mortality | 128 (8.7%) | 874 (14.7%) |
 Non-fatal CVEs | 287 (19.5%) | 880 (14.8%) |
 ACS | 217 (14.8%) | 615 (10.4%) |
 Stroke/TIA | 31 (2.1%) | 150 (2.5%) |
 Repeat revascularization | 39 (2.6%) | 115 (1.9%) |